Neuroprotective properties of resveratrol and derivatives

Tristan Richard, Alison D. Pawlus, Marie Laure Iglésias, Eric Pedrot, Pierre Waffo-Teguo, Jean Michel Mérillon, Jean Pierre Monti

Research output: Contribution to journalArticlepeer-review

181 Scopus citations


Stilbenoid compounds consist of a family of resveratrol derivatives. They have demonstrated promising activities in vitro and in vivo that indicate they may be useful in the prevention of a wide range of pathologies, such as cardiovascular diseases and cancers, as well have anti-aging effects. More recently stilbenoid compounds have shown promise in the treatment and prevention of neurodegenerative disorders, such as Huntington's, Parkinson's, and Alzheimer's diseases. This paper primarily focuses on the impact of stilbenoids in Alzheimer's disease and more specifically on the inhibition of β-amyloid peptide aggregation.

Original languageEnglish (US)
Pages (from-to)103-108
Number of pages6
JournalAnnals of the New York Academy of Sciences
Issue number1
StatePublished - Jan 2011


  • Alzheimer's disease
  • Inhibition of aggregation
  • Stilbenoid
  • β-amyloid peptide


Dive into the research topics of 'Neuroprotective properties of resveratrol and derivatives'. Together they form a unique fingerprint.

Cite this